Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

3/7/2024 RNC Pharma: Online Sales on Veterinary Market Double in January 2024

In January 2024, 2.1 billion rubles’ worth of veterinary drugs were sold on the Russian veterinary retail market (retail prices, VAT included), up 11.8% from January 2023. In physical terms, 16.5 million minimum dosage units (MDU) were sold, up 7.6% from January 2023.

2/22/2024 RNC Pharma: Russian Pharma Retail Ready to Resume Investing Activities

Russian Pharmacy Chain Rankings in 2023

2/15/2024 Inflation Rates in the Russian Pharmaceutical Retail Market in 2023

In 2023, veterinary drugs on the Russian retail market (e-com included) went up in price 26.6% from 2022. The highest price growth rates were seen in early 2023 (Fig. 1); as a result of the devaluation of the ruble and the subsequent correction of prices for imported goods on the Russian market, inflation surged in June–August 2023.

2/14/2024 RNC Pharma: Market Share of Top Russian Pharma Distributors Grows

Russian Pharmaceutical Distributor Rankings in 2023

2/13/2024 RNC Pharma: Analog Mercury Thermometers Most Stable in Demand in 2023

In 2023, 9.9 million medical thermometers worth 3.3 billion rubles (retail prices, VAT included) were sold on the Russian retail market (online sales included), down 12% in physical and down 15.7% in monetary terms from 2022.

All news [400]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.